Verwiel Frank
Insider CIK 1545794 · ACHN Director · ITMN Director · NTLA Director · AVXS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 35,148 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 25,948 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-06-17 | 2024-06-20 | 1,505 | $25.00 | $37.6K | 17,948 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-06-12 | 2024-06-14 | 11,515 | — | $0 | 11,515 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-06-12 | 2024-06-14 | 7,737 | — | $0 | 19,453 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-06-14 | 2023-06-16 | 6,473 | — | $0 | 6,473 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-06-14 | 2023-06-16 | 4,425 | — | $0 | 11,716 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 7,291 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-06-23 | 2021-06-25 | 3,382 | — | $0 | 3,382 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2021-06-23 | 2021-06-25 | 2,094 | — | $0 | 2,094 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-06-18 | 2020-06-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 42,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2019-05-21 | 2019-05-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2019-01-23 | 2019-01-25 | 42,000 | — | $0 | 42,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-05-17 | 2018-05-21 | 19,000 | — | $0 | 19,000 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 26,496 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 2,454 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer deriv | 2018-05-15 | 2018-05-15 | 2,905 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | D To issuer | 2018-05-15 | 2018-05-15 | 1,106 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2018-03-13 | 2018-03-30 | 2,905 | — | $0 | 2,905 | SEC↗ |
| AVXS AveXis, Inc. | A Award | 2018-03-13 | 2018-03-30 | 1,106 | — | $0 | 1,106 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-02-09 | 2018-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2017-07-25 | 2017-07-25 | 38,000 | — | $0 | 38,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2017-05-30 | 2017-06-01 | 2,454 | — | $0 | 2,454 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2017-01-19 | 2017-01-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 8,385 | — | $0 | 8,385 | SEC↗ |
| AVXS AveXis, Inc. | A Award deriv | 2016-02-10 | 2016-02-12 | 18,111 | — | $0 | 18,111 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2016-01-25 | 2016-01-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2015-12-14 | 2015-12-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 10,500 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 6,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 6,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 4,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 8,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer | 2014-09-29 | 2014-10-01 | 9,725 | $74.00 | $719.6K | 0 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-05-30 | 2014-06-02 | 3,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-05-30 | 2014-06-02 | 3,000 | — | $0 | 9,725 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2012-06-04 | 2012-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award | 2012-06-04 | 2012-06-06 | 2,500 | $10.10 | $25.3K | 6,725 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2012-04-06 | 2012-04-13 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2012-04-06 | 2012-04-13 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award | 2012-04-06 | 2012-04-13 | 625 | — | $0 | 4,225 | SEC↗ |
| ITMN INTERMUNE INC | A Award | 2012-04-06 | 2012-04-13 | 3,600 | — | $0 | 3,600 | SEC↗ |